Miguel Forte

Miguel Forte is Chief Executive Officer, Zelluna Immunotherapy and Chief Commercialization Officer and Chair of Commercialization Committee, International Society for Cell and Gene Therapy (ISCT).

Content by Miguel Forte:

Manufacture Advanced Medicine

The TCRs Are Coming

12/14/2019 | Miguel Forte

Miguel Forte argues it’s time to fine tune the way we target solid tumors...

Manufacture Advanced Medicine

Advanced Medicines: Making it to Market

08/19/2019 | Miguel Forte

When it comes to developing cell and gene therapies, you need to keep your eye on the end goal of commercial manufacturing.

Discovery & Development Drug Discovery

Now for the High-Hanging Fruit

01/22/2019 | Miguel Forte

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine